Back to search

Molecule Structure

Scientific Name


Description of the Drug

Finerenone is a nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)


Company Owner(s)

Bayer Healthcare Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Mineralocorticoid receptor SINGLE PROTEIN ANTAGONIST CHEMBL1994

Unichem Links

DrugBank DB16165
PubChem: Thomson Pharma 144081174
PubChem 60150535
Nikkaji J3.584.878I
EPA CompTox Dashboard DTXSID10146928
ChemicalBook CB72744895
Guide to Pharmacology 8678